Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. (Record no. 21125285)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01997 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516053435.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201203s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1365-2036 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1111/j.1365-2036.2011.04823.x |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Pinter, M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120315 |
245 00 - TITLE STATEMENT | |
Title | Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Alimentary pharmacology & therapeutics |
Date of publication, distribution, etc. | Oct 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 949-59 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzenesulfonates |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Hepatocellular |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Magnetic Resonance Imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Niacinamide |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenylurea Compounds |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Severity of Illness Index |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sorafenib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Statistics as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tomography, X-Ray Computed |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sieghart, W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hucke, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Graziadei, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vogel, W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Maieron, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Königsberg, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Weissmann, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kornek, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Matejka, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stauber, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Buder, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grünberger, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schöniger-Hekele, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Müller, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Peck-Radosavljevic, M |
773 0# - HOST ITEM ENTRY | |
Title | Alimentary pharmacology & therapeutics |
Related parts | vol. 34 |
-- | no. 8 |
-- | p. 949-59 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1111/j.1365-2036.2011.04823.x">https://doi.org/10.1111/j.1365-2036.2011.04823.x</a> |
Public note | Available from publisher's website |
No items available.